# Remodulin

NDC: 66302-101
Generic name: treprostinil
Labeler / Manufacturer: United Therapeutics Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20020522

FDA application: NDA021272

## Active ingredients

- TREPROSTINIL: 20 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66302-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66302-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c80bb38-e8db-4138-9f0d-dbbf9c673185